Our present results indicate that this approach with anti-RET kinase inhibitors could even be more successful for treating the FIPA somatotroph adenomas that are so aggressive and resistant to surgery and the usual medical therapy with agonists. This evidence concerns the gene RET and growth hormone-secreting pituitary adenoma.